Hao Peng

机构：Guangzhou Medical University Cancer Hospital, Guangzhou Medical University · ORCID：0000-0002-9726-6440

发表论文 8 篇 · 总被引 173 次 · h-index 6

代表论文

• [18F]FAPI PET/CT in the evaluation of focal liver lesions with [18F]FDG non-avidity (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 61)
• Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma (2023 · Cancer Imaging · 被引 55)
• Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma (2023 · Cell Death and Disease · 被引 18)
• Head-to-head study of [18F]FAPI-04 PET/CT and [18F]FDG PET/CT for non-invasive assessment of liver cancer and its immunohistochemical markers (2024 · BMC Cancer · 被引 14)
• Diagnostic performance of [18F]FAPI-04 PET/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT/MRI (2025 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 13)
• Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT (2024 · EJNMMI Research · 被引 10)